← 產業報告目錄

Veterinary Assistive Reproduction Technology Market Size, Share & Trends Analysis Report By Animal Type (Bovine, Swine, Ovine, Caprine, Equine, Other Animals), By Product (Normal Semen, Sexed Semen), By Distribution Channel (Private, Public), By Conception Method (Artificial Insemination, Embryo Transfer (MOET), IVF), By Region, And By Segment Forecasts, 2025-2034.

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-25頁數 179報告編號 INSIGHTACE-19b335c061

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

The worldwide Veterinary Assistive Reproduction Technology Market stood at USD 2.66 Bn in 2024, and is forecasted to reach USD 5.48 Bn by 2034, recording a CAGR of 7.6% from 2025 through 2034. Veterinary Assistive Reproduction Technology encompasses any method of treatment or procedure that alters the reproductive cycle, gametes, or embryos in some way. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges. Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Veterinary Assistive Reproduction Technologies Market Snapshot Chapter 4. Global Veterinary Assistive Reproduction Technologies Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Industry Analysis – Porter's Five Forces Analysis 4.6. Competitive Landscape & Market Share Analysis 4.7. Technology Advancement in Veterinary Assistive Reproduction Technologies Market 4.8. Key Trends in the Market Chapter 5. Market Segmentation 1: Animal Type Estimates & Trend Analysis 5.1. Animal Type & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type: 5.2.1. Bovine 5.2.2. Swine 5.2.3. Ovine 5.2.4. Caprine 5.2.5. Equine 5.2.6. Other Animals Chapter 6. Market Segmentation 2: Product Estimates & Trend Analysis 6.1. Product & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product: 6.2.1. Normal Semen 6.2.2. Sexed Semen Chapter 7. Market Segmentation 3: Distribution Channel Estimates & Trend Analysis 7.1. Distribution Channel & Market Share, 2024 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel: 7.2.1. Private 7.2.2. Public Chapter 8. Market Segmentation 4: Conception Method Estimates & Trend Analysis 8.1. Conception Method & Market Share, 2024 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Conception Method: 8.2.1. Artificial Insemination 8.2.2. Embryo Transfer (MOET) 8.2.3. IVF Chapter 9. Veterinary Assistive Reproduction Technologies Market Segmentation 6: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034 9.1.2. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034 9.1.3. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034 9.1.4. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034 9.1.5. North America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.1.5.1. U.S. 9.1.5.2. Canada 9.2. Europe 9.2.1. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034 9.2.2. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034 9.2.3. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034 9.2.4. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034 9.2.5. Europe Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) by country, 2021-2034 9.2.5.1. Germany 9.2.5.2. France 9.2.5.3. Italy 9.2.5.4. Spain 9.2.5.5. UK 9.2.5.6. Rest of Europe 9.3. Asia Pacific 9.3.1. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, 2021-2034 9.3.2. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034 9.3.3. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034 9.3.4. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034 9.3.5. Asia Pacific Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.3.5.1. China 9.3.5.2. India 9.3.5.3. Japan 9.3.5.4. Australia 9.3.5.5. Rest of Asia Pacific 9.4. Latin America 9.4.1. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million) 9.4.2. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034 9.4.3. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034 9.4.4. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034 9.4.5. Latin America Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034 9.4.5.1. Brazil 9.4.5.2. Rest of Latin America 9.5. MEA 9.5.1. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Animal Type, (US$ Million) 2021-2034 9.5.2. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Product, 2021-2034 9.5.3. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Conception Method, 2021-2034 9.5.4. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2021-2034 9.5.5. MEA Veterinary Assistive Reproduction Technologies Market revenue (US$ Million) estimates and forecasts by country, (US$ Million) 2021-2034 9.5.5.1. GCC Countries 9.5.5.2. South Africa 9.5.5.3. Rest of MEA Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Genus Plc 10.2.2. URUS Group LP 10.2.3. CRV 10.2.4. SEMEX 10.2.5. Select Sires, Inc. 10.2.6. Swine Genetics International 10.2.7. National Dairy Development Board 10.2.8. STgenetics 10.2.9. VikingGenetics 10.2.10. Geno SA 10.2.11. Other Prominent Player

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們